PM360 2021 Trailblazer Awards Cardiology Brand Champion Patrick L. Sutton

Patrick L. Sutton, Executive Director, Patient & Specialty Services, Cardio-Renal-Metabolic, Novartis Pharmaceuticals Corporation

Healthcare providers (HCPs) are experts when it comes to medicine. However, in many cases, administrative tasks such as specialty drug acquisition and the reimbursement process remain an ongoing challenge. Enter Patrick Sutton, who spearheaded a unique approach when preparing for the launch of an investigational product within Novartis’ Cardio-Renal-Metabolic franchise.

Novartis is committed to reimagining medicine. Part of this commitment is to deliver innovative, specialty medications that advance treatments in new ways that may require providers and patients to become familiar with different processes. For example, shifting a treatment landscape from one historically comprised of self-administered medications to include HCP-administered products. Careful consideration is required to effectively enable seamless integration into an HCP’s workflow and patient’s healthcare routine.

To achieve this, Patrick and his team conducted extensive discovery research to uncover and address non-clinical barriers to treatment in the relevant disease area. Their learnings were transformed into an unbranded campaign that included a website, educational presentations, and a series of educational videos that explain and simplify the specialty drug acquisition and reimbursement processes for office staff, with the goal of meeting them where they are, irrespective of their prior non-clinical experience.

They also reimagined patient support to deliver a simple, reliable, and supportive customer experience upon FDA approval of the investigational product. These combined campaigns will better position customers to understand the evolving landscape of drug acquisition and enable them to initiate timely use of therapies that benefit their patients.

With Patrick’s leadership style anchored in Novartis’ core values, establishing trust between these practices and Novartis is central to creating a strong foundation for future relationships.

Ads

You May Also Like

ELITE 2019 Data Miner Whitney Kemper of Crossix

Whitney Kemper VP, Analytics Products Crossix The Data Set Connecter Whitney Kemper is taking ...

What Makes a Leader

“Innovation distinguishes between a leader and a follower.” This quote from Steve Jobs is ...

ELITE 2021 Drug Researchers and Developers Bobak Azamian and Michael Ackermann of Tarsus Pharmaceuticals, Inc.

Bobak Azamian President, CEO, and Co-Founder Tarsus Pharmaceuticals, Inc. Michael Ackermann Chairman and Co-Founder ...